DentalCare Logo
CE 581 A History and Update of Fluoride Dentifrices

Cardiovascular Drugs Our Patients Take

COURSE NUMBER: 581

David Ojeda Diaz, DDS; Michaell A. Huber, DDS

Credit Hours:

3 Hour(s)

PDF

This course (1) presents an overview of cardiovascular pharmacology, (2) identifies prevalent cardiovascular diagnoses in ambulatory settings based on the mechanisms of action of cardiovascular drugs dispensed by U.S. community pharmacies, ...

View More

(Use this feature to create assignments for your students and staff.)

Overview

This course (1) presents an overview of cardiovascular pharmacology, (2) identifies prevalent cardiovascular diagnoses in ambulatory settings based on the mechanisms of action of cardiovascular drugs dispensed by U.S. community pharmacies, and (3) discusses key points for practice.

  • Intended Audience:

    Dentists, Dental Hygienists, Dental Students, Dental Hygiene Students

  • Date Course Online:

    Mar 1, 2019

  • Last Revision Date:

    Feb 28, 2023

  • Course Expiration Date:

    Feb 27, 2026

  • Cost:

    Free

  • Method:

    Self-instructional

  • AGD Subject Code(s):

    16

  • Technical Requirements:

    Stable internet connection and the latest version of browser and device software are recommended.

Learning Objectives

Upon the completion of this course, the dental professional should be able to:


  • Recognize cardiovascular drugs by name.
  • Discuss the mechanisms of action of cardiovascular drugs.
  • Identify prevalent cardiovascular diseases.
  • Discuss key points for practice.

Disclaimers

  • P&G is providing these resource materials to dental professionals. We do not own this content nor are we responsible for any material herein.

  • Participants must always be aware of the hazards of using limited knowledge in integrating new techniques or procedures into their practice.  Only sound evidence-based dentistry should be used in patient therapy.


Note:  Registration is required to take test.

Author(s)

Conflict of Interest Disclosure Statement

  • Dr. Ojeda Díaz reports no conflicts of interest associated with this course.

  • Dr. Huber has done consulting work for Procter & Gamble and serves on the dentalcare.com Advisory Board.

David Ojeda Diaz

David Ojeda Diaz

DDS

Clinical Assistant Professor of Oral Medicine Department of Comprehensive Dentistry The University of Texas Health Science Center at San Antonio School of Dentistry


Dr. David Ojeda Díaz received his DDS from the Santa Maria Universit...

View More
Michaell A. Huber

Michaell A. Huber

DDS

Submission Information

Academy of General Dentistry (AGD) Submission For credit transfers to appear in your AGD account in real time, make sure to add your AGD membership number in the field provided on the “Share Your Test Score” page.


CE Broker For all states that use CE Broker for licensure, “proof of completions” are electronically reported the first of every month. If a course was taken in November, the “proof of completion” will be submitted the beginning of December.

Recognition

AGD Pace Logo

Approved PACE Program Provider

THE PROCTER & GAMBLE COMPANY


Nationally Approved PACE Program Provider for FAGD/MAGD credit.

Approval does not imply acceptance by any regulatory authority or AGD endorsement.


8/1/2021 to 7/31/2027

Provider ID# 211886

AADH Logo

AADH Approved Program Provider

Procter & Gamble is designated as an approved Provider by the American Academy of Dental Hygiene, Inc. #AADHPGC (January 1, 2024-December 31, 2025). Approval does not imply acceptance by a state or provincial Board of Dentistry. Licensee should maintain this document in the event of an audit.